BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16885894)

  • 1. [Severe chloroquine- and hydroxychloroquine-induced retinopathy].
    Ingster-Moati I; Bui Quoc E; Crochet M; Orssaud C; Dufier JL; Roche O
    J Fr Ophtalmol; 2006 Jun; 29(6):642-50. PubMed ID: 16885894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ophthalmologic prevention of chloroquine and hydroxychloroquine induced retinopathy].
    Bui Quoc E; Ingster-Moati I; Rigolet MH; Chosidow O; Bodaghi B
    Ann Dermatol Venereol; 2005 Apr; 132(4):329-37. PubMed ID: 15886559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.
    Wei LC; Chen SN; Ho CL; Kuo YH; Ho JD
    Chang Gung Med J; 2001 May; 24(5):329-34. PubMed ID: 11480331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimalarial drug retinopathy].
    Guiot A; Couturier M; Tebib JG; Abouaf L; Coury F
    Rev Med Interne; 2018 May; 39(5):364-368. PubMed ID: 29496271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography.
    Cabral RTS; Klumb EM; Couto MINN; Carneiro S
    Arq Bras Oftalmol; 2019; 82(1):12-17. PubMed ID: 30403262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
    Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R
    Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
    Rüther K; Foerster J; Berndt S; Schroeter J
    Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifocal pattern electroretinogram in chloroquine retinopathy.
    Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
    Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction.
    Kellner U; Kraus H; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):94-7. PubMed ID: 10664060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine-induced retinopathy: a dermatologic perspective.
    Tripp JM; Maibach HI
    Am J Clin Dermatol; 2006; 7(3):171-5. PubMed ID: 16734504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and prevention of maculopathy associated with antimalarial agents.
    Easterbrook M
    Int Ophthalmol Clin; 1999; 39(2):49-57. PubMed ID: 10343924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine retinopathy after short-term therapy.
    Phillips BN; Chun DW
    Retin Cases Brief Rep; 2014; 8(1):67-9. PubMed ID: 25372212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retinal pigment epithelium--the point about safety of antimalarial agents].
    Vanheesbeke A
    Bull Soc Belge Ophtalmol; 2007; (304):47-58. PubMed ID: 17718227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular effects and safety of antimalarial agents.
    Easterbrook M
    Am J Med; 1988 Oct; 85(4A):23-9. PubMed ID: 3177429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.
    Kobak S; Deveci H
    Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular toxicity due to 4-aminoquinoline derivatives].
    Gouveia EB; Morales MS; Gouveia GB; Lourenzi VP
    Arq Bras Oftalmol; 2007; 70(6):1046-51. PubMed ID: 18235926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy.
    Bernstein HN
    Am J Med; 1983 Jul; 75(1A):25-34. PubMed ID: 6869408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine retinopathy.
    Weiner A; Sandberg MA; Gaudio AR; Kini MM; Berson EL
    Am J Ophthalmol; 1991 Nov; 112(5):528-34. PubMed ID: 1951589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.